Fertility-sparing approach for endometrial cancer: the role of office hysteroscopy

References

• Surveillance E. and End Results Program. Cancer Stat Facts: Uterine cancer; 2021. Available from: http://seer.cancer.gov/statfacts/html/corp.html.
   Google Scholar
• Felix AS, Weissfeld JL, Stone RA, et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control. 2010;21(11):1851–1856.
   PubMed Web of Science ®Google Scholar
• Duska LR, Garrett A, Rueda BR, et al. Endometrial cancer in women 40 years old or younger. Gynecol Oncol. 2001;83(2):388–393.
   PubMed Web of Science ®Google Scholar
• Lee NK, Cheung MK, Shin JY, et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007;109:655–662.
   PubMed Web of Science ®Google Scholar
• Ota T, Yoshida M, Kimura M, et al. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer. 2005;15(4):657–662.
   PubMed Web of Science ®Google Scholar
• Abdelazim IA, Abu-Faza M, Zhurabekova G, et al. Sentinel lymph nodes in endometrial cancer update 2018. Gynecol Minim Invasive Ther. 2019;8(3):94–100.
   PubMed Web of Science ®Google Scholar
• Panici PB, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707–1716.
   PubMedGoogle Scholar
• Casarin J, Bogani G, Piovano E, et al. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma. J Gynecol Oncol. 2020;31(5):e64.
   PubMed Web of Science ®Google Scholar
• Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–136.
   PubMed Web of Science ®Google Scholar
• Polcher M, Rottmann M, Brugger S, et al. Lymph node dissection in endometrial cancer and clinical outcome: a population-based study in 5546 patients. Gynecol Oncol. 2019;154(1):65–71.
   PubMed Web of Science ®Google Scholar
• Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017;18(3):384–392.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Rossetti D, Tropea A, et al. Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg. 2017;69(1):29–34.
   PubMed Web of Science ®Google Scholar
• Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine neoplasms, Version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(2):170–199.
   PubMed Web of Science ®Google Scholar
• Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125(2):477–482.
   PubMed Web of Science ®Google Scholar
• Ben-Baruch G, Seidman DS, Schiff E, et al. Outpatient endometrial sampling with the Pipelle curette. Gynecol Obstet Invest. 1994;37(4):260–262.
   PubMed Web of Science ®Google Scholar
• Larson DM, Johnson KK, Broste SK, et al. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol. 1995;86(1):38–42.
   PubMed Web of Science ®Google Scholar
• Stock RJ, Kanbour A. Prehysterectomy curettage. Obstet Gynecol. 1975;45(5):537–541.
   PubMedGoogle Scholar
• Bedner R, Rzepka-Gorska I. Hysteroscopy with directed biopsy versus dilatation and curettage for the diagnosis of endometrial hyperplasia and cancer in perimenopausal women. Eur J Gynaecol Oncol. 2007;28:400–402.
   PubMed Web of Science ®Google Scholar
• Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. Jama. 2002;288(13):1610–1621.
   PubMed Web of Science ®Google Scholar
• Gkrozou F, Dimakopoulos G, Vrekoussis T, et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet. 2015;291(6):1347–1354.
   PubMed Web of Science ®Google Scholar
• Ferrari F, Forte S, Arrigoni G, et al. Impact of endometrial sampling technique and biopsy volume on the diagnostic accuracy of endometrial cancer. Transl Cancer Res Tcr. 2020;9(12):7697–7705.
   Web of Science ®Google Scholar
• Revel A, Tsafrir A, Anteby SO, et al. Does hysteroscopy produce intraperitoneal spread of endometrial cancer cells? Obstet Gynecol Surv. 2004;59(4):280–284.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim HD, Song YS, et al. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr. 1995;19(5):766–772.
   PubMed Web of Science ®Google Scholar
• Practice Bulletin No. 149: endometrial cancer. Obstet Gynecol. 2015;125:1006–1026.
   PubMed Web of Science ®Google Scholar
• Obermair A, Baxter E, Brennan DJ, et al. Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstet Gynecol Sci. 2020;63(4):417–431.
   PubMedGoogle Scholar
• Raffone A, Travaglino A, Saccone G, et al. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2019;98(8):976–987.
   PubMed Web of Science ®Google Scholar
• Raffone A, Travaglino A, Zullo FM, et al. Predictive accuracy of progesterone receptor B in young women with atypical endometrial hyperplasia and early endometrial cancer treated with hysteroscopic resection plus LNG-IUD insertion. J Minim Invasive Gynecol. 2020;28(6):1244–1253.
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, et al. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018;231:104–110.
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, et al. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand. 2019;98(9):1086–1099.
   PubMed Web of Science ®Google Scholar
• Raffone A, Travaglino A, Flacco ME, et al. Clinical predictive factors of response to treatment in patients undergoing conservative management of atypical endometrial hyperplasia and early endometrial cancer. J Adolesc Young Adult Oncol. 2020;10(2):193–201.
   PubMed Web of Science ®Google Scholar
• Raffone A, Travaglino A, Saccone G, et al. Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecol Endocrinol. 2019;35(11):932–937.
   PubMed Web of Science ®Google Scholar
• Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71(3):677–685.
   PubMed Web of Science ®Google Scholar
• Qin Y, Yu Z, Yang J, et al. Oral progestin treatment for early-stage endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2016;26(6):1081–1091.
   PubMed Web of Science ®Google Scholar
• Ramirez PT, Frumovitz M, Bodurka DC, et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95(1):133–138.
   PubMed Web of Science ®Google Scholar
• Rodolakis A, Biliatis I, Morice P, et al. European Society of Gynecological Oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int J Gynecol Cancer. 2015;25(7):1258–1265.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Riemma G, Carugno J, et al. Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives. Transl Cancer Res Tcr. 2020;9(12):7767–7777.
   Web of Science ®Google Scholar
• Wei J, Zhang W, Feng L, et al. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review. Medicine (Baltimore). 2017;96(37):e8034.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Bruni S, Chiofalo B, et al. Updates in office hysteroscopy: a practical decalogue to perform a correct procedure. Updates Surg. 2020;72(4):967–976.
   PubMed Web of Science ®Google Scholar
• Garuti G, Mirra M, Luerti M. Hysteroscopic view in atypical endometrial hyperplasias: a correlation with pathologic findings on hysterectomy specimens. J Minim Invasive Gynecol. 2006;13(4):325–330.
   PubMed Web of Science ®Google Scholar
• Mazzon I, Corrado G, Morricone D, et al. Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection. Int J Gynecol Cancer. 2005;15(5):974–978.
   PubMed Web of Science ®Google Scholar
• Arendas K, Aldossary M, Cipolla A, et al. Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature. J Minim Invasive Gynecol. 2015;22(1):34–39.
   PubMed Web of Science ®Google Scholar
• Vitale SG. The biopsy snake grasper sec. VITALE: a new tool for office hysteroscopy. J Minim Invasive Gynecol. 2020;27(6):1414–1416.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Lagana AS, Caruso S, et al. Comparison of three biopsy forceps for hysteroscopic endometrial biopsy in postmenopausal patients (HYGREB-1): a multicenter, single-blind randomized clinical trial. Int J Gynaecol Obstet. 2021;1–8. DOI: https://doi.org/10.1002/ijgo.13669
   Google Scholar
• Erkanli S, Ayhan A. Fertility-sparing therapy in young women with endometrial cancer: 2010 update. Int J Gynecol Cancer. 2010;20(7):1170–1187.
   PubMed Web of Science ®Google Scholar
• De Marzi P, Bergamini A, Luchini S, et al. Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy. J Minim Invasive Gynecol. 2015;22(7):1178–1182.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Qi G, Kanis MJ, et al. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. Oncotarget. 2017;8(34):57642–57653.
   PubMedGoogle Scholar
• Giampaolino P, Di Spiezio Sardo A, Mollo A, et al. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study. J Minim Invasive Gynecol. 2019;26(4):648–656.
   PubMed Web of Science ®Google Scholar
• Laurelli G, Falcone F, Gallo MS, et al. Long-term oncologic and reproductive outcomes in young women with early endometrial cancer conservatively treated: a prospective study and literature update. Int J Gynecol Cancer. 2016;26(9):1650–1657.
   PubMed Web of Science ®Google Scholar
• Gallos ID, Yap J, Rajkhowa M, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207:266 e1–12.
   PubMed Web of Science ®Google Scholar
• Alonso S, Castellanos T, Lapuente F, et al. Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature. Ecancermedicalscience. 2015;9:505.
   PubMed Web of Science ®Google Scholar
• Ben-Arie A, Tamir S, Dubnik S, et al. Does hysteroscopy affect prognosis in apparent early-stage endometrial cancer? Int J Gynecol Cancer. 2008;18(4):813–819.
   PubMed Web of Science ®Google Scholar
• Vilos GA, Edris F, Al-Mubarak A, et al. Hysteroscopic surgery does not adversely affect the long-term prognosis of women with endometrial adenocarcinoma. J Minim Invasive Gynecol. 2007;14(2):205–210.
   PubMed Web of Science ®Google Scholar
• Hahn HS, Yoon SG, Hong JS, et al. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer. 2009;19(6):1068–1073.
   PubMed Web of Science ®Google Scholar
• Park JY, Kim DY, Kim JH, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer. 2013;49(4):868–874.
   PubMed Web of Science ®Google Scholar